Acro Biomedical Co Stock Price on January 6, 2023
| ACBM Stock | USD 0 0.00 0.00% |
If you're considering investing in ACRO Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of ACRO Biomedical stands at 0, as last reported on the 12th of December 2024, with the highest price reaching 0 and the lowest price hitting 0 during the day. We have found three technical indicators for ACRO Biomedical Co, which you can use to evaluate the volatility of the entity.
ACRO Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
ACRO |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ACBM |
Based on monthly moving average ACRO Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ACRO Biomedical by adding ACRO Biomedical to a well-diversified portfolio.
Related Headline
Mineralys Therapeutics, Headline on 9th of February 2023
Mineralys Therapeutics, exotic insider transaction detected by Akkaraju Srinivas
Filed transaction by Mineralys Therapeutics In director. Unconventional Insider trading
ACRO Biomedical Valuation on January 6, 2023
It is possible to determine the worth of ACRO Biomedical on a given historical date. On January 6, 2023 ACRO was worth 4.5 at the beginning of the trading date compared to the closed value of 4.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ACRO Biomedical pink sheet. Still, in general, we apply an absolute valuation method to find ACRO Biomedical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACRO Biomedical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ACRO Biomedical's related companies.
| Open | High | Low | Close | Volume | |
| 4.50 | 4.50 | 4.50 | 4.50 | 1.00 | |
01/06/2023 | 4.50 | 4.50 | 4.50 | 4.50 | 1.00 |
| 4.50 | 4.50 | 4.50 | 4.50 | 1.00 |
| Backtest ACRO Biomedical | | | ACRO Biomedical History | | | ACRO Biomedical Valuation | Previous | Next |
ACRO Biomedical Trading Date Momentum on January 6, 2023
| On January 09 2023 ACRO Biomedical Co was traded for 4.50 at the closing time. The top price for the day was 4.50 and the lowest listed price was 4.50 . There was no trading activity during the period 1.0. Lack of trading volume on January 9, 2023 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
ACRO Biomedical Fundamentals Correlations and Trends
By evaluating ACRO Biomedical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ACRO Biomedical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ACRO financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ACRO Biomedical Pink Sheet history
ACRO Biomedical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ACRO is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ACRO Biomedical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ACRO Biomedical stock prices may prove useful in developing a viable investing in ACRO Biomedical
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
ACRO Biomedical Pink Sheet Technical Analysis
ACRO Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
ACRO Biomedical Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
ACRO Biomedical Co cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ACRO Biomedical December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how ACRO Biomedical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ACRO Biomedical shares will generate the highest return on investment. By undertsting and applying ACRO Biomedical pink sheet market strength indicators, traders can identify ACRO Biomedical Co entry and exit signals to maximize returns
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.